Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge
July 2013
Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge.
Americans spend $60 billion a year trying to lose weight.
The health benefits are significant IF they succeed. Just a 5% to 10% drop in weight can improve blood pressure, lipids, and glucose.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote